Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE study): Examination of posttreatment drinking outcomes

Journal of Studies on Alcohol and Drugs

Volumn 69, Issue 1, 2008, Pages 5-13

  Donovan, Dennis M ^a,b   Anton, Raymond F ^a,c   Miller, William R ^a,d   Longabaugh, Richard ^a,e   Hosking, James D ^a,f   Youngblood, Marston ^a,f  

^a Alcohol and Drug Abuse Institute   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

^e BROWN UNIVERSITY   (United States)

^f IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; NALTREXONE; PLACEBO;

ALCOHOLISM; ARTICLE; BEHAVIOR THERAPY; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 38049064904     PISSN: 19371888     EISSN: 19384114     Source Type: Journal    
DOI: 10.15288/jsad.2008.69.5     Document Type: Article

References (36)

1. ANTON, R.F., MOAK, D.H., LATHAM, P.K., WAID, L.R., MALCOLM, R.J., DIAS, J.K., AND ROBERTS, J.S. Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism. J. Clin. Psychopharmacol. 21: 72-77, 2001.
2. ANTON, R.F., O'MALLEY, S.S., CIRAULO, D.A., OSLER, R.A., COUPER, D., DONOVAN, D.M., GASTFRIEND, D.R., HOSKING, J.D., JOHNSON, B.A., LOCASTRO, J.S., LONGABAUGH, R., MASON, B.J., MATTSON, M.E., MILLER, W.R., PETTINATI, H.M., RANDALL, C.L., SWIFT, R., WEISS, R.D., WILLIAMS, L.D., ZWEBEN, A., AND COMBINE STUDY RESEARCH GROUP. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study. A randomized controlled trial. JAMA 295: 2003-2017, 2006.
3. BOUZA, C., ANGELES, M., MUNOZ, A., AND AMATE, J.M. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: A systematic review. Addiction 99: 811-828, 2004.
4. BRESLIN, F.C., SOBELL, M.B., SOBELL, L.C., BUCHAN, G., AND CUNNINGHAM, J.A. Toward a stepped care approach to treating problem drinkers: The predictive utility of within-treatment variables and therapist prognostic ratings. Addiction 92: 1479-1489, 1997.
5. CISLER, R.A. AND ZWEBEN, A. Development of a composite measure for assessing alcohol treatment outcome: Operationalization and validation. Alcsm Clin. Exp. Res. 23: 263-271, 1999.
6. COMBINE STUDY RESEARCH GROUP. Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: Rationale and methods. Alcsm Clin. Exp. Res. 27: 1107-1122, 2003.
7. FARREN, C.K. AND O'MALLEY, S. Sequential use of naltrexone in the treatment of relapsing alcoholism. Amer. J. Psychiat. 154: 714, 1997.
8. FIRST, M.B., SPITZER, R.L., GIBBON, M., AND WILLIAMS, J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0), New York: New York State Psychiatric Institute, 1995.
9. KRANZLER, H.R. AND VAN KIRK, J. Efficacy of naltrexone and acamprosate for alcoholism treatment: A meta-analysis. Alcsm Clin. Exp. Res. 25: 1335-1341, 2001.
10. MCKAY, J.R. Effectiveness of continuing care interventions for substance abusers: Implications for the study of long-term treatment effects. Eval. Rev. 25: 211-232, 2001a.
11. MCKAY, J.R. The role of continuing care in outpatient alcohol treatment programs. In: GALANTER, M. (Ed.) Recent Developments in Alcoholism, Vol. 15: Service Research in the Era of Managed Care, New York: Kluwer Academic/Plenum, 2001b, pp. 357-372.
12. MCKAY, J.R. Is there a case for extended interventions for alcohol and drug use disorders? Addiction 100: 1594-1610, 2005.
13. MCLELLAN, A.T. Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. Addiction 97: 249-252, 2002.
14. MCLELLAN, A.T., LEWIS, D.C., O'BRIEN, C.P., AND KLEBER, H.D. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA 284: 1689-1695, 2000.
15. MCLELLAN, A.T., MCKAY, J.R., FORMAN, R., CACCIOLA, J., AND KEMP, J. Reconsidering the evaluation of addiction treatment: From retrospective follow-up to concurrent recovery monitoring. Addiction 100: 447-458, 2005.
16. MANN, K. Pharmacotherapy of alcohol dependence: A review of the clinical data. CNS Drugs 18: 485-504, 2004.
17. MANN, K., LEHERT, P., AND MORGAN, M. Y. The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: Results of a meta-analysis. Alcsm Clin. Exp. Res. 28: 51-63, 2004.
18. MASON, B.J. Treatment of alcohol-dependent outpatients with acamprosate: A clinical review. J. Clin. Psychiat. 62 (Suppl. No. 20): 42-48, 2001.
19. MILLER, W.R. Form 90: A Structured Assessment Interview for Drinking and Related Behaviors: Test Manual. NIAAA Project MATCH Monograph Series, Vol. 5, NIH Publication No. 96-4004, Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism, 1996.
20. MILLER, W.R. (Ed.) Combined Behavioral Intervention Manual: A Clinical Research Guide for Therapists Treating People with Alcohol Abuse and Dependence. NIAAA COMBINE Monograph Servies, Vol. 1. DHHS Publication No. 04-5288, Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism, 2004.
21. MILLER, W.R. AND DEL BOCA, F.K. Measurement of drinking behavior using the Form 90 family of instruments. J. Stud. Alcohol, Supplement No. 12, pp. 112-118, 1994.
22. MILLER, W.R., LOCASTRO, J.S., LONGABAUGH, R., O'MALLEY, S., AND ZWEBEN, A. When worlds collide: Blending the divergent traditions of pharmacotherapy and psychotherapy outcome research. J. Stud. Alcohol, Supplement No. 15, pp. 17-23, 2005.
23. MILLER, W.R., TONIGAN, J.S., AND LONGABAUGH, R. The Drinker Inventory of Consequences (DrInC): An Instrument for Assessing Adverse Consequences of Alcohol Abuse (Test Manual). NIAAA Project MATCH Monograph Series, Vol. 4, NIH Publication No. 95-3911, Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism, 1995.
24. MOYER, A. AND FINNEY, J.W. Outcomes for untreated individuals involved in randomized trials of alcohol treatment. J. Subst. Abuse Treat. 23: 247-252, 2002.
25. O'MALLEY, S.S., JAFFE, A.J., CHANG, G. RODE, S., SCHOTTENFELD, R., MEYER, R.E., AND ROUNSAVILLE, B. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch. Gen. Psychiat. 53: 217-224. 1996.
26. O'MALLEY, S.S., ROUNSAVILLE, B.J., FARREN, C., NAMKOONG, K., WU, R., ROBINSON, J., AND O'CONNOR, P.G. Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: A nested sequence of 3 randomized trials. Arch. Intern. Med. 163: 1695-1704, 2003.
27. PETTINATI, H.M., WEISS, R.D., MILLER, W.R., DONOVAN, D., ERNST, D.B., AND ROUNSAVILLE, B.J. Medical Management (MM) Treatment Manual: A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of the Treatment for Alcohol Dependence. NIAAA COMBINE Monograph Series, Vol. 2, DHHS Publication No. 04-5289, Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism, 2004.
28. SASS, H., SOYKA, M., MANN, K., AND ZIEGLGANSBERGER, W. Relapse prevention by acamprosate: Results from a placebo-controlled study on alcohol dependence. Arch. Gen. Psychiat. 53: 673-680, 1996.
29. SOYKA, M. AND CHICK, J. Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: A European perspective. Amer. J. Addict. 12 (Suppl. 1): S69-S80, 2003.
30. SRISURAPANONT, M. AND JARUSURAISIN, N. Naltrexone for the treatment of alcoholism: A meta-analysis of randomized controlled trials. Int. J. Neuropsychopharmacol. 8: 267-280, 2005.
31. STOUT, R.L., RUBIN, A., ZWICK, W., ZYWIAK, W., AND BELLINO, L. Optimizing the cost-effectiveness of alcohol treatment: A rationale for extended case monitoring. Addict. Behav. 24: 17-35, 1999.
32. STREETON, C. AND WHELAN, G. Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: A meta-analysis of randomized controlled trials. Alcohol Alcsm 36: 544-552, 2001.
33. WATKINS, K., PINCUS, H.A., TANELIAN, T.L., AND LLOYD, J. Using the chronic care model to improve treatment of alcohol use disorders in primary care settings. J. Stud. Alcohol 64: 209-218, 2003.
34. WEISS, R.D., LOCASTRO, J.S., SWIFT, R., ZWEBEN, A., MILLER, W.R., LONGABAUGH, R., AND HOSKING, J.D. Use of a "psychotherapy with no pills" treatment condition as part of a combined pharmacotherapy- psychotherapy research study of alcohol dependence. J. Stud. Alcohol, Supplement No. 15, pp. 43-49, 2005.
35. WHITWORTH, A.B., FISCHER, F., LESCH, O.M., NIMMERRICHTER, A., OBERBAUER, H., PLATZ, T., POTGIETER, A., WALTER, H., AND FLEISCHHACKER, W.W. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 347: 1438-1442, 1996.
36. ZWEBEN, A. AND CISLER, R.A. Clinical and methodological utility of a composite outcome measure for alcohol treatment research. Alcsm Clin. Exp. Res. 27: 1680-1685, 2003.